vs

Side-by-side financial comparison of ANGIODYNAMICS INC (ANGO) and RMR GROUP INC. (RMR). Click either name above to swap in a different company.

ANGIODYNAMICS INC is the larger business by last-quarter revenue ($79.4M vs $66.7M, roughly 1.2× RMR GROUP INC.). RMR GROUP INC. runs the higher net margin — 18.3% vs -8.0%, a 26.3% gap on every dollar of revenue. On growth, RMR GROUP INC. posted the faster year-over-year revenue change (40.8% vs 9.0%).

AngioDynamics Inc is a global medical technology firm that designs, manufactures and sells a portfolio of minimally invasive medical devices. Its core offerings cover vascular access, surgical ablation, and oncology care solutions, serving hospitals, outpatient surgery centers and other healthcare providers across North America, Europe and Asia Pacific.

RMR Group Inc. is a U.S.-headquartered alternative asset management firm specializing in real estate and real estate-related investments. It operates across commercial property, residential real estate, and infrastructure segments, serving institutional investors, high-net-worth individuals, and retail clients across key global markets.

ANGO vs RMR — Head-to-Head

Bigger by revenue
ANGO
ANGO
1.2× larger
ANGO
$79.4M
$66.7M
RMR
Growing faster (revenue YoY)
RMR
RMR
+31.7% gap
RMR
40.8%
9.0%
ANGO
Higher net margin
RMR
RMR
26.3% more per $
RMR
18.3%
-8.0%
ANGO

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
ANGO
ANGO
RMR
RMR
Revenue
$79.4M
$66.7M
Net Profit
$-6.3M
$12.2M
Gross Margin
56.4%
Operating Margin
-7.7%
48.1%
Net Margin
-8.0%
18.3%
Revenue YoY
9.0%
40.8%
Net Profit YoY
40.9%
91.1%
EPS (diluted)
$-0.15
$0.71

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANGO
ANGO
RMR
RMR
Q4 25
$79.4M
$66.7M
Q3 25
$75.7M
Q2 25
$80.2M
Q1 25
$72.0M
Q4 24
$72.8M
Q3 24
$67.5M
Q2 24
$71.0M
Q1 24
$75.2M
Net Profit
ANGO
ANGO
RMR
RMR
Q4 25
$-6.3M
$12.2M
Q3 25
$-10.9M
Q2 25
$-6.0M
Q1 25
$-4.4M
Q4 24
$-10.7M
Q3 24
$-12.8M
Q2 24
$-13.4M
Q1 24
$-187.7M
Gross Margin
ANGO
ANGO
RMR
RMR
Q4 25
56.4%
Q3 25
55.3%
Q2 25
52.7%
Q1 25
54.0%
Q4 24
54.8%
Q3 24
54.4%
Q2 24
54.3%
Q1 24
47.7%
Operating Margin
ANGO
ANGO
RMR
RMR
Q4 25
-7.7%
48.1%
Q3 25
-14.1%
Q2 25
-7.2%
Q1 25
-13.9%
Q4 24
-15.2%
Q3 24
-19.4%
Q2 24
-20.4%
Q1 24
-265.9%
Net Margin
ANGO
ANGO
RMR
RMR
Q4 25
-8.0%
18.3%
Q3 25
-14.4%
Q2 25
-7.5%
Q1 25
-6.1%
Q4 24
-14.7%
Q3 24
-19.0%
Q2 24
-18.9%
Q1 24
-249.7%
EPS (diluted)
ANGO
ANGO
RMR
RMR
Q4 25
$-0.15
$0.71
Q3 25
$-0.26
Q2 25
$-0.15
Q1 25
$-0.11
Q4 24
$-0.26
Q3 24
$-0.31
Q2 24
$-0.35
Q1 24
$-4.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANGO
ANGO
RMR
RMR
Cash + ST InvestmentsLiquidity on hand
$41.6M
$49.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$176.3M
$232.7M
Total Assets
$269.7M
$687.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANGO
ANGO
RMR
RMR
Q4 25
$41.6M
$49.3M
Q3 25
$38.8M
Q2 25
$55.9M
Q1 25
$44.8M
Q4 24
$54.1M
Q3 24
$55.0M
Q2 24
$76.1M
Q1 24
$78.5M
Total Debt
ANGO
ANGO
RMR
RMR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$0
Q1 24
Stockholders' Equity
ANGO
ANGO
RMR
RMR
Q4 25
$176.3M
$232.7M
Q3 25
$178.9M
Q2 25
$183.0M
Q1 25
$185.9M
Q4 24
$186.8M
Q3 24
$196.6M
Q2 24
$205.6M
Q1 24
$218.7M
Total Assets
ANGO
ANGO
RMR
RMR
Q4 25
$269.7M
$687.1M
Q3 25
$265.6M
Q2 25
$280.1M
Q1 25
$285.4M
Q4 24
$291.6M
Q3 24
$293.6M
Q2 24
$317.7M
Q1 24
$324.8M
Debt / Equity
ANGO
ANGO
RMR
RMR
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.00×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANGO
ANGO
RMR
RMR
Operating Cash FlowLast quarter
$4.7M
$10.7M
Free Cash FlowOCF − Capex
$4.2M
FCF MarginFCF / Revenue
5.3%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
0.88×
TTM Free Cash FlowTrailing 4 quarters
$-9.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANGO
ANGO
RMR
RMR
Q4 25
$4.7M
$10.7M
Q3 25
$-15.9M
Q2 25
$18.8M
Q1 25
$-13.2M
Q4 24
$2.5M
Q3 24
$-18.3M
Q2 24
$5.0M
Q1 24
$-12.5M
Free Cash Flow
ANGO
ANGO
RMR
RMR
Q4 25
$4.2M
Q3 25
$-16.6M
Q2 25
$18.0M
Q1 25
$-15.0M
Q4 24
$1.7M
Q3 24
$-19.3M
Q2 24
$4.4M
Q1 24
$-13.1M
FCF Margin
ANGO
ANGO
RMR
RMR
Q4 25
5.3%
Q3 25
-22.0%
Q2 25
22.5%
Q1 25
-20.8%
Q4 24
2.3%
Q3 24
-28.7%
Q2 24
6.2%
Q1 24
-17.5%
Capex Intensity
ANGO
ANGO
RMR
RMR
Q4 25
0.5%
Q3 25
1.0%
Q2 25
1.0%
Q1 25
2.5%
Q4 24
1.1%
Q3 24
1.6%
Q2 24
0.8%
Q1 24
0.8%
Cash Conversion
ANGO
ANGO
RMR
RMR
Q4 25
0.88×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANGO
ANGO

Med Device$37.2M47%
Med Tech$30.4M38%
Other$11.8M15%

RMR
RMR

Management Service Incentive$23.6M35%
Industrial Logistics Properties Trust$15.1M23%
Managed Private Real Estate Capital$11.1M17%
Office Properties Income Trust$5.6M8%
Other Private Entities$5.3M8%
RMR Residential$3.4M5%
Sonesta International Hotels Corporation$2.1M3%
Investment Advisory Management And Administrative Service$1.2M2%

Related Comparisons